{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:22:57Z","timestamp":1792423377277,"version":"4.5.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.1048","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:10:30Z","timestamp":1646413830000},"page":"e221048","source":"Crossref","is-referenced-by-count":31,"title":["Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals"],"prefix":"10.1001","volume":"5","author":[{"given":"Girish N.","family":"Nadkarni","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhen","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hauser","sequence":"additional","affiliation":[{"name":"Institute for Family Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Bagiella","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Ellis","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Sanderson","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Scott","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Sema4, A Mount Sinai Venture, Stamford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Sabin","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony","family":"Madden","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Loyola University Medical School, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pollak","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Calman","sequence":"additional","affiliation":[{"name":"Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Institute for Family Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin P.","family":"Bottinger","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Digital Health Center, Hasso Plattner Institute, Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol R.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"6","key":"zoi220058r1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.ajkd.2016.05.030","article-title":"Risk of ESRD in the United States.","volume":"68","author":"Albertus","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"zoi220058r2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0272-6386(88)80221-X","article-title":"Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.","volume":"12","author":"McClellan","year":"1988","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"zoi220058r3","doi-asserted-by":"publisher","first-page":"15900","DOI":"10.1038\/s41598-018-34233-w","article-title":"Surveillance of CKD epidemiology in the US\u2014a joint analysis of NHANES and KEEP.","volume":"8","author":"Myers","year":"2018","journal-title":"Sci Rep"},{"issue":"5993","key":"zoi220058r4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"23","key":"zoi220058r5","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease.","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi220058r6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans.","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"zoi220058r7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jmoldx.2015.11.003","article-title":"Analytical validation of a personalized medicine APOL1 genotyping assay for nondiabetic chronic kidney disease risk assessment.","volume":"18","author":"Zhang","year":"2016","journal-title":"J Mol Diagn"},{"issue":"6","key":"zoi220058r8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrneph.2011.52","article-title":"The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.","volume":"7","author":"Rosset","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"zoi220058r9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11906-011-0237-4","article-title":"Target organ damage in African American hypertension: role of APOL1.","volume":"14","author":"Freedman","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"15","key":"zoi220058r10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.2018.10960","article-title":"Race, ancestry, and reporting in medical journals.","volume":"320","author":"Cooper","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi220058r11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ackd.2016.01.017","article-title":"Genomics in CKD: is this the path forward?","volume":"23","author":"Nadkarni","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"zoi220058r12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/j.ajkd.2018.02.351","article-title":"Genetic testing in clinical settings.","volume":"72","author":"Franceschini","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"zoi220058r13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/clpt.2014.137","article-title":"Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.","volume":"96","author":"Rasmussen-Torvik","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi220058r14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.ackd.2014.12.001","article-title":"Management of hypertension in CKD: beyond the guidelines.","volume":"22","author":"Judd","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"zoi220058r15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003166","article-title":"Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension.","volume":"10","author":"Gu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"zoi220058r16","author":"Nadkarni","journal-title":"AMIA Annu Symp Proc"},{"issue":"2","key":"zoi220058r17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.kint.2016.09.033","article-title":"Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.","volume":"91","author":"Ku","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"zoi220058r18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2954","article-title":"Clinical decision support for recognition and management of hypertension: a randomized trial.","volume":"141","author":"Kharbanda","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"zoi220058r19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archinternmed.2011.604","article-title":"Impact of electronic health records on racial and ethnic disparities in blood pressure control at US primary care visits.","volume":"172","author":"Samal","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"zoi220058r20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1053\/j.ajkd.2018.07.017","article-title":"African American living donors\u2019 attitudes about APOL1 genetic testing: a mixed methods study.","volume":"72","author":"Gordon","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"zoi220058r21","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2215\/CJN.01510218","article-title":"The APOL1 Long-Term Kidney Transplantation Outcomes Network\u2014APOLLO.","volume":"13","author":"Freedman","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"zoi220058r22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2015.12.020","article-title":"Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry.","author":"Horowitz","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"zoi220058r24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"zoi220058r26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/clpt.2013.72","article-title":"The CLIPMERGE PGx program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.","volume":"94","author":"Gottesman","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi220058r27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1353\/hpu.2017.0020","article-title":"Race, genomics and chronic disease: what patients with African ancestry have to say.","volume":"28","author":"Horowitz","year":"2017","journal-title":"J Health Care Poor Underserved"},{"key":"zoi220058r28","journal-title":"Genet Med"},{"issue":"7","key":"zoi220058r29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1097\/01.ASN.0000129982.10611.4C","article-title":"Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.","volume":"15","author":"McClellan","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"zoi220058r30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1681\/ASN.2005111200","article-title":"Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.","volume":"17","author":"McClellan","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"9731","key":"zoi220058r31","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"zoi220058r32","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis.","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"12","key":"zoi220058r33","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.jacc.2017.01.040","article-title":"Apolipoprotein L1 variants and blood pressure traits in African Americans.","volume":"69","author":"Nadkarni","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"zoi220058r34","doi-asserted-by":"crossref","first-page":"i1102","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"zoi220058r35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJMoa1011893","article-title":"Effect of direct-to-consumer genomewide profiling to assess disease risk.","volume":"364","author":"Bloss","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi220058r36","doi-asserted-by":"publisher","first-page":"1251.e1","DOI":"10.1016\/j.amjmed.2015.05.011","article-title":"Integration of genomics in primary care.","volume":"128","author":"Larson","year":"2015","journal-title":"Am J Med"},{"issue":"1","key":"zoi220058r37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10897-017-0158-8","article-title":"Projecting the supply and demand for certified genetic counselors: a workforce study.","volume":"27","author":"Hoskovec","year":"2018","journal-title":"J Genet Couns"},{"issue":"2","key":"zoi220058r38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1353\/cpr.2017.0020","article-title":"A culture of understanding: reflections and suggestions from a genomics research community board.","volume":"11","author":"Kaplan","year":"2017","journal-title":"Prog Community Health Partnersh"},{"issue":"5","key":"zoi220058r39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1377\/hlthaff.2017.1548","article-title":"Views of primary care providers on testing patients for genetic risks for common chronic diseases.","volume":"37","author":"Hauser","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"zoi220058r40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0002-9149(99)00635-9","article-title":"Elevated systolic blood pressure as a cardiovascular risk factor.","volume":"85","author":"Kannel","year":"2000","journal-title":"Am J Cardiol"},{"issue":"7624","key":"zoi220058r41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","article-title":"Genomics is failing on diversity.","volume":"538","author":"Popejoy","year":"2016","journal-title":"Nature"},{"key":"zoi220058r23","unstructured":"Equator Network. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Accessed December 13, 2021. https:\/\/www.equator-network.org\/reporting-guidelines\/consort\/"},{"key":"zoi220058r25","unstructured":"Agency for Healthcare Research and Quality. The SHARE approach. Accessed December 3, 2018. https:\/\/www.ahrq.gov\/professionals\/education\/curriculum-tools\/shareddecisionmaking\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2789618\/nadkarni_2022_oi_220058_1645727145.34894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:10:37Z","timestamp":1646413837000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2789618"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1048","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]}}}